相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents
Daniel Gonzalez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Results from the Solithromycin International Surveillance Program (2014)
David J. Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota
Mamun-Ur Rashid et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The solithromycin journey-It is all in the chemistry
Prabhavathi Fernandes et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia
Thomas M. File et al.
CLINICAL INFECTIOUS DISEASES (2016)
The role of solithromycin in the management of bacterial community-acquired pneumonia
Francoise Van Bambeke et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)
Carlos M. Barrera et al.
LANCET INFECTIOUS DISEASES (2016)
Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment
Brian D. Jamieson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antimicrobial Activity of Solithromycin against Serotyped Macrolide-Resistant Streptococcus pneumoniae Isolates Collected from US Medical Centers in 2012
D. J. Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones
Francoise Van Bambeke
ANNALS OF MEDICINE (2014)
Antimicrobial Activity of Solithromycin against Clinical Isolates of Legionella pneumophila Serogroup 1
Julia Mallegol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae
Giorgio Piccinelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: In vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes/serogroups
Nathalie M. Vandevelde et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Macrolide antibiotics allosterically predispose the ribosome for translation arrest
Shanmugapriya Sothiselvam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
David Oldach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae
Ward Rodgers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition
Y. Kobayashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
George G. Zhanel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Regulation of Gene Expression by Macrolide-Induced Ribosomal Frameshifting
Pulkit Gupta et al.
MOLECULAR CELL (2013)
A Novel Macrolide Solithromycin Exerts Superior Anti-inflammatory Effect via NF-κB Inhibition
Yoshiki Kobayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?
Daniel Golparian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparison of Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Solithromycin (CEM-101) in Healthy Adult Subjects
Keith A. Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antibiotics in development targeting protein synthesis
Joyce A. Sutcliffe
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action
Krishna Kannan et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
J. Gordon Still et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
Shannon D. Putnam et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
Patricia M. Roblin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms
Pamela McGhee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Determination of CEM-101 Activity Tested against Clinical Isolates of Neisseria meningitidis from a Worldwide Collection
Douglas J. Biedenbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
Daniel Bertrand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
Beatriz Llano-Sotelo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
CEM-101 Activity against Gram-Positive Organisms
Leah N. Woosley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria
Shannon D. Putnam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
David J. Farrell et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
David J. Farrell et al.
JOURNAL OF INFECTION (2010)
Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101
Ken B. Waites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Telithromycin-Associated Hepatotoxicity: Clinical Spectrum and Causality Assessment of 42 Cases
Allen D. Brinker et al.
HEPATOLOGY (2009)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Antimicrobial resistance in Haemophilus influenzae
Stephen Tristram et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Review of macrolides and ketolides - Focus on respiratory tract infections
GG Zhanel et al.
DRUGS (2001)
β-keto-ester chemistry and ketolides.: Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides
A Denis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Macrolide drug interactions: An update
MP Pai et al.
ANNALS OF PHARMACOTHERAPY (2000)
分享论文
